title: [Cavernous tissue rehabilitation whit sildenafil 100 mg in patients after radical prostatectomy].
abstract: OBJECTIVE
  We try to figure out whether early penile rahabilitation ameliorates erectile dysfunction secondary to radical prostatectomy.
  
  
  METHODS
  Retrospective study of 80 cases of patients that were operated between 2005-2008; all of them went under radical prostatectomy and were treated with sildenafil 100 mg every second day (Monday, Wednesday and Friday) plus 100 mg on demand after the surgery. As objective measurements, we used validated questionnaire IIEF-5 and also axil penile rigidity before and after surgery in the third and ninth month.
  
  
  RESULTS
  Patients treated with sildenafil in fixed doses presented a 60% full erection recovery 9 months after radical prostatectomy. In the case where patients underwent bilateral or unilateral nerve sparing, they got a successful rate of almost 90%. Even 20% of those patients who did not have a nerve preservation got satisfactory erections,
  
  
  CONCLUSIONS
  Our experience shows that early penile rehabilitation seems to be a good treatment for erectile dysfunction after radical prostatectomy with IPDE5 in fixed doses. Administration every other day plus on demand looks like also as an appropriate option.
authors: Servicio de Urología, Hospital del Henares, Coslada, Madrid, España. mfvd@eresmas.com
authors: Manuel
authors: M
authors: Fernández Arjona
authors: Luis M
authors: LM
authors: Herranz Fernández
authors: Pablo
authors: P
authors: Garrido
authors: Milagros
authors: M
authors: Jiménez
authors: Carlos
authors: C
authors: Suárez
authors: Inmaculada
authors: I
authors: Fernández
mesh_terms: D000368:Aged; D003950:Diagnostic Techniques, Urological / Q000295:instrumentation; D004867:Equipment Design; D007172:Erectile Dysfunction / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology* / Q000534:rehabilitation; D006801:Humans; D008297:Male; D008875:Middle Aged; D010726:Phosphodiesterase Inhibitors / Q000008:administration & dosage*; D010879:Piperazines / Q000008:administration & dosage*; D011468:Prostatectomy / Q000009:adverse effects*; D011687:Purines / Q000008:administration & dosage; D012189:Retrospective Studies; D000068677:Sildenafil Citrate; D013450:Sulfones / Q000008:administration & dosage*
chemical_list: D010726:Phosphodiesterase Inhibitors; D010879:Piperazines; D011687:Purines; D013450:Sulfones; D000068677:Sildenafil Citrate